hotspot -WSS

hotspot

author：entertainment 2025-10-06 11:41:28 - browse：7

Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT — Adobe

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： The CDC's new social media misinformation war

WSS

What’s missing from the debate over nursing home staff minimums

Readout LOUD: Venture capital, Gilead, and more M&A

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Devoted Health’s losses in Medicare Advantage persist

Problems with a popular proposal to regulate AI in health care

entertainment

hotspot

Wikipedia

What does generative AI mean for health care? We asked experts

Ohio still needs to do more to protect the right to abortion

Medicare details structure of new drug price negotiation program

Weight loss drugs should be covered by insurers, AMA says

Novavax promises a turnaround & Lilly roils the obesity market

340B reform proposal comes out of Senate working group

In age of alternative facts, a scholarly course on calling out crap

Today's health inequities arise from racist U.S. history, say experts

Hollywood unions extend contract negotiations for actors

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

focus

Medicare’s new pay boost for primary care is angering specialists

Publishing genetic code of viruses could cause disaster

What is STAT's opinion section for?

Experimental asthma app from Apple and Anthem shows promise

AstraZeneca stays mum on Medicare drug pricing negotiations

340B reform proposal comes out of Senate working group

hotspot

hotspot

hotspot

entertainment